The mechanism of pristimerin enhances chemosensitivity of cisplatin to conditionally reprogrammed primary lung adenocarcinoma cells

SHI Yi, ZHONG Yan, LIU Xiaohu, KE Zunfu, CHEN Xiao, TANG Yubo.
The Journal of Practical Medicine . 2022, (7): 841 -847 .  DOI: 10.3969/j.issn.1006⁃5725.2022.07.012